BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 31633505)

  • 1. Characteristics of Dexmedetomidine Postconditioning in the Field of Myocardial Ischemia-Reperfusion Injury.
    Bunte S; Behmenburg F; Majewski N; Stroethoff M; Raupach A; Mathes A; Heinen A; Hollmann MW; Huhn R
    Anesth Analg; 2020 Jan; 130(1):90-98. PubMed ID: 31633505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Ischemic Postconditioning on Myocardial Function and Infarct Size Following Reperfusion Injury in Diabetic Rats Pretreated With Vildagliptin.
    Bayrami G; Karimi P; Agha-Hosseini F; Feyzizadeh S; Badalzadeh R
    J Cardiovasc Pharmacol Ther; 2018 Mar; 23(2):174-183. PubMed ID: 28901167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dexmedetomidine Provides Cardioprotection During Early or Late Reperfusion Mediated by Different Mitochondrial K+-Channels.
    Raupach A; Karakurt E; Torregroza C; Bunte S; Feige K; Stroethoff M; Brandenburger T; Heinen A; Hollmann MW; Huhn R
    Anesth Analg; 2021 Jan; 132(1):253-260. PubMed ID: 32889843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of the Phosphodiesterase Inhibitors Sildenafil and Milrinone Induces Cardioprotection With Various Conditioning Strategies.
    Torregroza C; Maas K; Feige K; Raupach A; Stroethoff M; Heinen A; Hollmann MW; Huhn R
    J Cardiovasc Pharmacol; 2020 Dec; 76(6):684-691. PubMed ID: 33002964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Ca
    Stroethoff M; Bunte S; Raupach A; van de Snepscheut M; Torregroza C; Heinen A; Mathes A; Hollmann MW; Huhn R; Sixt SU
    Cardiovasc Drugs Ther; 2019 Oct; 33(5):581-588. PubMed ID: 31705225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melatonin Receptor Agonist Ramelteon Reduces Ischemia-Reperfusion Injury Through Activation of Mitochondrial Potassium Channels.
    Stroethoff M; Christoph I; Behmenburg F; Raupach A; Bunte S; Senpolat S; Heinen A; Hollmann MW; Mathes A; Huhn R
    J Cardiovasc Pharmacol; 2018 Aug; 72(2):106-111. PubMed ID: 29787401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of Hyperglycemia on Dexmedetomidine-Induced Cardioprotection in the Isolated Perfused Rat Heart.
    Torregroza C; Feige K; Schneider L; Bunte S; Stroethoff M; Heinen A; Hollmann MW; Huhn R; Raupach A
    J Clin Med; 2020 May; 9(5):. PubMed ID: 32413983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential role of EphrinA2 receptors in postconditioning induced cardioprotection in rats.
    Kaur K; Singh N; Dhawan RK
    Eur J Pharmacol; 2020 Sep; 883():173231. PubMed ID: 32589885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cardioprotective effect of dexmedetomidine on regional ischemia/reperfusion injury in type 2 diabetic rat hearts.
    Deng L; Chen H; Wei N; Zhang Z; Wang G
    Microvasc Res; 2019 May; 123():1-6. PubMed ID: 30179598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dexmedetomidine Maintains Its Direct Cardioprotective Effect Against Ischemia/Reperfusion Injury in Hypertensive Hypertrophied Myocardium.
    Yoshikawa Y; Hirata N; Kawaguchi R; Tokinaga Y; Yamakage M
    Anesth Analg; 2018 Feb; 126(2):443-452. PubMed ID: 28914648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined remote perconditioning and postconditioning failed to attenuate infarct size and contractile dysfunction in a rat model of coronary artery occlusion.
    Sachdeva J; Dai W; Gerczuk PZ; Kloner RA
    J Cardiovasc Pharmacol Ther; 2014 Nov; 19(6):567-73. PubMed ID: 24607766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin and GSK3β-inhibition abrogates the infarct sparing-effect of ischemic postconditioning in ex vivo rat hearts.
    Helgeland E; Wergeland A; Sandøy RM; Askeland M; Aspevik A; Breivik L; Jonassen AK
    Scand Cardiovasc J; 2017 Jun; 51(3):159-166. PubMed ID: 28276718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B-type natriuretic peptide at early reperfusion limits infarct size in the rat isolated heart.
    Burley DS; Baxter GF
    Basic Res Cardiol; 2007 Nov; 102(6):529-41. PubMed ID: 17896117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lovastatin interferes with the infarct size-limiting effect of ischemic preconditioning and postconditioning in rat hearts.
    Kocsis GF; Pipis J; Fekete V; Kovács-Simon A; Odendaal L; Molnár E; Giricz Z; Janáky T; van Rooyen J; Csont T; Ferdinandy P
    Am J Physiol Heart Circ Physiol; 2008 May; 294(5):H2406-9. PubMed ID: 18359895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxytocin exerts protective effects on in vitro myocardial injury induced by ischemia and reperfusion.
    Ondrejcakova M; Ravingerova T; Bakos J; Pancza D; Jezova D
    Can J Physiol Pharmacol; 2009 Feb; 87(2):137-42. PubMed ID: 19234577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P2X7 receptor agonists pre- and postcondition the heart against ischemia-reperfusion injury by opening pannexin-1/P2X₇ channels.
    Vessey DA; Li L; Kelley M
    Am J Physiol Heart Circ Physiol; 2011 Sep; 301(3):H881-7. PubMed ID: 21685263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rosuvastatin postconditioning protects isolated hearts against ischemia-reperfusion injury: The role of radical oxygen species, PI3K-Akt-GSK-3β pathway, and mitochondrial permeability transition pore.
    Liu CW; Yang F; Cheng SZ; Liu Y; Wan LH; Cong HL
    Cardiovasc Ther; 2017 Feb; 35(1):3-9. PubMed ID: 27580017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delayed postconditioning in the mouse heart in vivo.
    Roubille F; Franck-Miclo A; Covinhes A; Lafont C; Cransac F; Combes S; Vincent A; Fontanaud P; Sportouch-Dukhan C; Redt-Clouet C; Nargeot J; Piot C; Barrère-Lemaire S
    Circulation; 2011 Sep; 124(12):1330-6. PubMed ID: 21875909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardioprotective Properties of Mannitol-Involvement of Mitochondrial Potassium Channels.
    Feige K; Rubbert J; Raupach A; Stroethoff M; Heinen A; Hollmann MW; Huhn R; Torregroza C
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33673646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preconditioning by Levosimendan is Mediated by Activation of Mitochondrial Ca
    Bunte S; Behmenburg F; Bongartz A; Stroethoff M; Raupach A; Heinen A; Minol JP; Hollmann MW; Huhn R; Sixt SU
    Cardiovasc Drugs Ther; 2018 Oct; 32(5):427-434. PubMed ID: 30120617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.